维普中文期刊产品整合服务
419篇 您的检索式:作者名="FISHER M B"
    题名 作者 年代 出处 被引量
1Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors显示文摘AIM:To evaluate systemic treatment choices in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors(PNETs)and provide consensus treatment recommendations.METHODS:Systemic treatment options for pancreatic neuroendocrine tumors have expanded in recent years to include somatostatin analogs,angiogenesis inhibitors,inhibitors of mammalian target of rapamycinand cytotoxic agents.At this time,there is little data to guide treatment selection and sequence.We therefore assembled a panel of expert physicians to evaluate systemic treatment choices and provide consensus treatment recommendations.Treatment appropriateness ratings were collected using the RAND/UCLA modified Delphi process.After studying the literature,a multidisciplinary panel of 10 physicians assessed the appropriateness of various medical treatment scenarios on a 1-9 scale.Ratings were done both before and after an extended discussion of the evidence.Quantitative measurements of agreement were made and consensus statements developed from the second round ratings.RESULTS:Specialties represented were medical and surgical oncology,interventional radiology,and gastroenterology.Panelists had practiced for a mean of15.5 years(range:6-33).Among 202 rated scenarios,disagreement decreased from 13.2%(26 scenarios)before the face-to-face discussion of evidence to 1%(2)after.In the final ratings,46.5%(94 scenarios)were rated inappropriate,21.8%(44)were uncertain,and30.7%(62)were appropriate.Consensus statements from the scenarios included:(1)it is appropriate to use somatostatin analogs as first line therapy in patients with hormonally functional tumors and may be appropriate in patients who are asymptomatic;(2)it is appropriate to use everolimus,sunitinib,or cytotoxic chemotherapy therapy as first line therapy in patients with symptomatic or progressive tumors;and(3)beyond first line,these same agents can be used.In patients with uncontrolled secretory symptoms,octreotide LAR doses can be titrated up to 60 mg every4 wk or up to 40 mg every 3 or 4 wk.CONCLUSION:Using the Delphi process allowed physician experts to systematically obtain a consensus on the appropriateness of a variety of medical therapies in patients with PNETs.Jonathan R Strosberg George A Fisher Al B Benson Lowell B Anthony Bulent Arslan John F Gibbs Edward Greeno Renuka V Iyer Michelle K Kim William J Maples Philip A Philip Edward M Wolin Dasha Cherepanov Michael S Broder 2015World Journal of Gastroenterology2015,21,8:2
2Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression显示文摘Yoo Byoung Kwon Emdad Luni Su Zao-zhong Villanueva Augusto Chiang Derek Y Mukhopadhyay Nitai D Mills Alan Scott Waxman Samuel Fisher Robert A Llovet Josep M Fisher Paul B Sarkar Devanand 2009Journal of Clinical Investigation2009,,3:2
3Direct least square fitting of ellipses显示文摘FITZGIBBON A PILU M FISHER R B 1999IEEE Transac tions on Pattern Analysis and Machine Intelli gence1999,21,5:1
4Five - year results of a randomized Clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treat ment of breast cancer 显示文摘Fisher B Bauer M Margolese R 1985N Engl J med1985,312,11:1
5Regulation of mda-7 gene expression during human melanoma differentiation显示文摘Madireddi M T Dent P Fisher P B 2000Oncogene2000,19,10:1
6Dislocation distributions in brown diamond显示文摘WILLEMS B MARTINEAU P M FISHER D 2006Physical Status Solid2006,12,:1
7Direct least square fitting of ellipses显示文摘Fitzgibbon A Pilu M Fisher R B 1999Pattern Analysis and Machine Intelligence IEEE Transactions on1999,21,:1
8Direct least square fitting of ellipses显示文摘FITZGIBBON A PILU M FISHER R B 1999IEEE Transactions on Pat- tern Analysis Machine Intelligence1999,21,5:1
9Direct least squares fitting of ellipses显示文摘Fitzgibbon A W Pilu M Fisher R B 1999IEEE Transactions on Pattern Analysis and Machine Intelligence1999,21,5:1
10Application ofphysiologically based pharmacokinetic models in chemical riskassessment显示文摘Mumtaz M Fisher J Blount B 2012J Toxicol2012,2012,9:1
11Downregulation of the ERK 1 and 2 mitogen activated protein kinases using antisense oligonucleotides inhihits proliferation of porcine vascular smooth muscle cells显示文摘Fisher M Liu B Glennon PE 2001Atheroselrosis2001,156,2:1
12Gonadotmphin-in- dueed follicle development in red deer hinds during the breeding and non-breeding seasons显示文摘MeLeed B J Meikle L M Fisher M W 2001Reproduction2001,122,1:1
13Direct least square fitting of ellipses显示文摘FLIZGIBBON A PILU M FISHER B 1999IEEE Trans Pattern Anal Mach lntell1999,21,5:1
14Gluose update during induced stress is insulin independent and enhanced by adrenergic blockade 显示文摘Lekas M Fisher S J Bahrani B 1999J Appl Physiol1999,87,:1
15Sedimentary structures in base-surge deposits with special reference to cross-bedding, Ubehebe Craters, Death Valley, California显示文摘CROWE B M FISHER R V 1973Geological Society of America Bulletin1973,84,:1
16Common Fixed Point Theorems in Complex Valued Metric Spaces 显示文摘Azam A Fisher B Khan M 2011Numer Funt Anal Optim2011,32,3:1
17Vehicle routing with time windows: two optimization algorithms 显示文摘Fisher M Jornsten K O Madsen O B 1997Operations Research1997,,45:1
18Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade 显示文摘LEKAS M FISHER SJ EJ BAHRANI B 1999J Appl Physiol1999,87,:1
19Factors associated with pressure ulcers in adults in acute care hospitals显示文摘FISHER A R WELLS G HARRISON M B 2004Holist Nurs Pract2004,18,5:1
20Experimental Fretting-Wear Studies of Steam Generator Materials显示文摘Fisher N J Chow A B Weckwerth M K 1995Journal of Pressure Vessel Technology1995,117,:1
返回顶部 每页显示:
共21页 首页 上一页 第1页 下一页 末页 /21 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费